| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2004 | CN1145641C Monomeric insulin analog formulations |
| 04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145636C C-4'-substituted macrolide derivatives |
| 04/14/2004 | CN1145635C Glucopyranosyloxypyrazole derivatives, medicinal comopsitions containing the same and intermediates in the production |
| 04/14/2004 | CN1145627C Pyrazolo [4,3-d] pyrimidines |
| 04/14/2004 | CN1145625C Process for the production of tert-buty1 (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methyl sulfonyl)amino]pyrimidin5-yl](4R,65)-2,2-dimethyl[1,3]dioxan-4-yl]acetate ]) |
| 04/14/2004 | CN1145624C New Process |
| 04/14/2004 | CN1145623C Imidazole derivatives |
| 04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
| 04/14/2004 | CN1145619C 1-4-benzothiazepine derivatives methods for preparation, medicaments containing same and use thereof |
| 04/14/2004 | CN1145618C Cycloformate derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/14/2004 | CN1145615C Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145609C Piperazine compounds and medical use thereof |
| 04/14/2004 | CN1145608C Quanternary ammonium compounds as anti-tussive agents |
| 04/14/2004 | CN1145606C 2-aminotetrahydronaphthalene, process for their preparation, and pharmaceutical composition for prevention and therapeutic treatment of in flammatory and lor autoimmune pathologies |
| 04/14/2004 | CN1145529C 催化剂组合物 The catalyst composition |
| 04/14/2004 | CN1145497C Enterogastric external nutrition composition and its pharmaceutic use thereof |
| 04/14/2004 | CN1145492C Metal/thiol biochdes |
| 04/14/2004 | CN1145490C Tseroid saponi glycoside for controlling animal's coccidiosis |
| 04/14/2004 | CN1145489C Inositol polyphosphate derivatives and mthod of using same |
| 04/14/2004 | CN1145488C Sustained-release microgranules containing diltiazem as active principle |
| 04/14/2004 | CN1145487C Use of allopurinol for medical purpose |
| 04/14/2004 | CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine |
| 04/14/2004 | CN1145485C 8-chloro-6,11-dihydro-11-(4-piperidy lidene)-5H-benzo[5,6] cyclohepta [1,2,-b] pyridine oral compositions |
| 04/14/2004 | CN1145484C Extended release tiagabine formulations with reduced side effects |
| 04/14/2004 | CN1145483C Levobupivacaine and its use as an anaesthetic in pregnant women |
| 04/14/2004 | CN1145482C Use of phanquinone for treating alzheimer's disease |
| 04/14/2004 | CN1145481C Use of thiazolidinone in preparing medicine for treating and preventing neudrodegenerative disorders |
| 04/14/2004 | CN1145480C Contraceptive for male |
| 04/14/2004 | CN1145479C Pharmaceutical Preparation |
| 04/14/2004 | CN1145478C Pharmaceutical aerosol formulation |
| 04/13/2004 | US6721595 Percutaneous absorption promoters for electroporation |
| 04/13/2004 | US6720453 Purity; thermodynamically stable |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720422 Amide substituted imidazopyridines |
| 04/13/2004 | US6720415 S-ribosylhomocysteine to homocysteine; bacterial genes involved in biosynthesis of the signaling molecule; bacterial autoinducer-2 signaling molecule; luminescence in the vibrio harveyi signaling system 2 bioassay; luxq luminescence genes |
| 04/13/2004 | US6720357 Sulfonamide derivatives |
| 04/13/2004 | US6720356 Magnesium di-potassium EDTA complex and method of administration |
| 04/13/2004 | US6720355 Antiseptics; acidity ph; destroying infections |
| 04/13/2004 | US6720354 Prevention of neutrophil recruitment |
| 04/13/2004 | US6720353 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units |
| 04/13/2004 | US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents |
| 04/13/2004 | US6720350 Reducing diminution in vessel lumen area with a therapeutic shunt having a cytoskeletal inhibitor to reduce stenosis or restenosis; taxols, cytochalasins |
| 04/13/2004 | US6720349 Benzimidazole derivatives and salts and prodrugs thereof |
| 04/13/2004 | US6720348 For therapy of diabetic neuropathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic retinopathy, diabetic microangiopathy, diabetic macroangiopathy, cataracts and foot ulcers |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720344 Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants |
| 04/13/2004 | US6720343 (((4-(3-thien-2-yl-1,2,4-oxadiazol-5-yl)phenyl)sulfonyl) amino)acetic acid, optionally substituted; selective matrix metalloprotease (mmp-2) inhibition; low protein binding, high blood concentration, no p-450 inhibition |
| 04/13/2004 | US6720342 Azabicyclic compounds used in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system. |
| 04/13/2004 | US6720341 Preventives/remedies for kidney diseases |
| 04/13/2004 | US6720340 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720337 Antitumor agents; synergistic mixtures; side effect reduction |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720333 Amide substituted imidazopyridines |
| 04/13/2004 | US6720332 Oxindole derivatives |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720318 Combination of cyamemazine and an atypical neuroleptic |
| 04/13/2004 | US6720316 Therapeutic 5-HT ligand compounds |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6720308 Anhydrolide derivatives having antibacterial activity |
| 04/13/2004 | US6720307 Antibiotic; against antibiotic resistant microorganisms |
| 04/13/2004 | US6720304 Conjugate comprising a folic acid antagonist and a carrier |
| 04/13/2004 | US6720184 Administering a fumonisin analog; treating neimann-picks syndrome or tay-sachs disease. |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6720004 Mixed witha polymeric carrier to produce a certain dissolution profile; follows a zero-order release pattern producing flat plasma levels of valproate, once steady-state levels have been achieved; side effect reduction |
| 04/13/2004 | US6720003 Preparing a solution of paroxetine hydrochloride or sertaline hydrochloride and a water-soluble carrier in a co-solvent of a volatile solvent and water, and drying the solution |
| 04/13/2004 | US6720002 Solubility and storage stability while maintaining bioavailability of drug |
| 04/13/2004 | US6720001 Emulsion compositions for polyfunctional active ingredients |
| 04/13/2004 | US6720000 Process for producing wet ribavirin pellets |
| 04/13/2004 | US6719998 Administering bisphosphonate or salt |
| 04/13/2004 | US6719997 Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers |
| 04/13/2004 | US6719996 Galenic composition for low bioavailability medicaments |
| 04/13/2004 | US6719995 Flexible polybutene strips for preventing gingivitis/whitening of teeth |
| 04/13/2004 | US6719994 Stability, dosage uniformity and tolerability of the formulation to the lungs |
| 04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
| 04/13/2004 | US6719963 Liquid oral compositions comprising a calcium compound and an acidulant |
| 04/13/2004 | US6719960 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 04/13/2004 | US6719805 Devices and methods for treating tissue |
| 04/13/2004 | US6719540 C3-cyano epothilone derivatives |
| 04/13/2004 | US6718986 Mixed chimerism and tolerance |
| 04/13/2004 | US6718910 Agents for promoting fattening of animals and method of promoting fattening |
| 04/13/2004 | CA2374877C Pharmaceutical formulations and methods comprising intranasal morphine |
| 04/13/2004 | CA2348090C Oral pulsed dose drug delivery system |
| 04/13/2004 | CA2311122C Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 04/13/2004 | CA2296035C Preparation of oxymorphone, oxycodone and derivatives |
| 04/13/2004 | CA2292248C Novel derivatives of 1,2-dithiolane, process for preparing them and pharmaceutical compositions containing them |
| 04/13/2004 | CA2261150C Methods for purifying nucleic acids |